
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Longitudinal antibody dynamics after COVID-19 vaccine boosters based on prior infection status and booster doses
Naomi Matsumoto, Ayako Sasaki, Tomoka Kadowaki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Naomi Matsumoto, Ayako Sasaki, Tomoka Kadowaki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
Ching‐Wen Hou, Stacy Williams, Veronica Boyle, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 61-61
Open Access
Ching‐Wen Hou, Stacy Williams, Veronica Boyle, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 61-61
Open Access
Increase in antibody titer and change over time associated with severe acute respiratory syndrome coronavirus 2 infection after mRNA vaccination: Consideration of the significance of additional vaccination
Hiroshi Kusunoki, Michiko Ohkusa, Rie Iida, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 3
Hiroshi Kusunoki, Michiko Ohkusa, Rie Iida, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 3
Seroprevalence of Anti-SARS-CoV-2, IgM and IgG, and COVID-19 Vaccine Uptake in Nairobi, Kenya: A Cross-Sectional Study
Agnes Muhonja Otindo, Eric M. Ndombi, Martin Theuri, et al.
(2024)
Open Access | Times Cited: 1
Agnes Muhonja Otindo, Eric M. Ndombi, Martin Theuri, et al.
(2024)
Open Access | Times Cited: 1
Kinetics of SARS-CoV-2 antibody titers after booster vaccinations during an Omicron surge in Japan
Naomi Matsumoto, Ayako Sasaki, Tomoka Kadowaki, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126156-126156
Closed Access | Times Cited: 1
Naomi Matsumoto, Ayako Sasaki, Tomoka Kadowaki, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126156-126156
Closed Access | Times Cited: 1
Long-Term Immunity Against SARS-CoV-2 Wild Type and Omicron XBB 1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Health Characteristics Associated With Persistence of SARS-CoV-2 Antibody Responses After Repeated Vaccinations in Older Persons Over Time: The Doetinchem Cohort Study
Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, et al.
Research Square (Research Square) (2024)
Closed Access
Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, et al.
Research Square (Research Square) (2024)
Closed Access
Health characteristics associated with persistence of SARS-CoV-2 antibody responses after repeated vaccinations in older persons over time: the Doetinchem cohort study
Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access
Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access
Seroprevalence of anti-SARS-CoV-2 IgM and IgG and COVID-19 vaccine uptake in healthy volunteers in Nairobi, Kenya: a cross-sectional study
Agnes Muhonja Otindo, Eric M. Ndombi, Martin Theuri, et al.
Frontiers in Virology (2024) Vol. 4
Open Access
Agnes Muhonja Otindo, Eric M. Ndombi, Martin Theuri, et al.
Frontiers in Virology (2024) Vol. 4
Open Access
Current Status and Significance of Additional Vaccination with COVID-19 Vaccine in Japan—Considerations from Antibody Levels from Hybrid Immunity and Public Perceptions
Hiroshi Kusunoki
Vaccines (2024) Vol. 12, Iss. 12, pp. 1413-1413
Open Access
Hiroshi Kusunoki
Vaccines (2024) Vol. 12, Iss. 12, pp. 1413-1413
Open Access
Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 72-72
Open Access
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 72-72
Open Access